Pulsecath and Terumo Europe signed combining technologies and distribution agreements

On April 20th 2015 both parties signed agreements that combine Terumo’s Solopath expandable sheath with Pulsecath’s iVAC 2L percutaneous short term pulsatile LVAD.
The Solopath SR-19/35 expand and re-collapsible Sheath will be merged with iVAC 2L as 13.5 Fr. reliable and easy to use introducing system. This technologies combination will create an attractive full percutaneous short term pulsatile LVAD to use in CathLabs with high risk PCI and cardiogenic shock patients.
As part of these agreements Terumo Europe will distribute, service and support the iVAC 2L in four European countries: Italy , Spain , Switzerland and France.
Both companies are going to launch this corporation during the PCR congress, Paris May 2015.

Leave a comment

Your email address will not be published.